OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
0.00
0.00%
0.583 / 0.6468 (4000 x 7000)
701 West Georgia Street, Suite 1500
Vancouver, BC V7Y 1C6
Canada
701 West Georgia Street, Suite 1500
Vancouver, BC V7Y 1C6
Canada
None
1140 West Pender Street
# 1500-1700
Vancouver, BC V6E EG1
Canada
555 Burrard Street
Suite 2501
Canada, BC V6C2B5
Canada
FendX is a nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens. We believe we are well positioned to develop products using our nanotechnology that will bring significant value in controlling the spread of surface borne infectious diseases.
The Company has a growing intellectual property portfolio consisting of licensed nonprovisional national stage patent applications which have been made in Canada, the United States, Europe, China (patent issued), Hong Kong and Japan, as well as two licensed PCT applications. Our licensed nanotechnology has been featured in CNN Health, Materials Today, and Engineering.com. Of more than 500 applicants, the lead researchers of the nanotechnology at McMaster University won the “Create The Future” Design Contest sponsored by Tech Briefs in 2020.